Skip to main content

Table 5 Risk factors for SECOND MONTH SMEAR NEGATIVATION among pulmonary tuberculosis patients from October 2009 to September 2010 (hierarchized model)

From: Effectiveness of RHZE-FDC (fixed-dose combination) compared to RH-FDC + Z for tuberculosis treatment in Brazil: a cohort study

Characteristics

%

OR

95%CI

adjOR

95%CI

FDC-RHZE

     

  No

66.4

1

 

1

 

  Yes

33.6

1.104

0.932 - 1.307

1.164

0.999 - 1.372

DOT

     

  No

75.9

1

 

1

 

  Yes

24.1

1.450

1.208 - 1.739

1.373

1.137 - 1.658

The unit assists over 125 cases yearly

  

  No

50.1

1

 

1

 

  Yes

49.9

0.782

0.663 - 0.922

0.817

0.686 - 0.974

The unit has exclusively primary care

  

  No

84.4

1

 

1

 

  Yes

15.6

1.289

1.065 - 1.559

1.336

1.099 - 2.126

  1. Bold numbers are statistically significant findings. FDC = fixed-dose combination; R = rifampin; H = isoniazid; Z = pyrazinamide; E = ethambutol, DOT = directly observed treatment; OR = odds ratio; adjOR = adjusted odds ration; CI = confidence interval.